Structure-based assessment of diseaserelated mutations in human voltage-gated sodium channels

Abstract

Voltage-gated sodium (Na_v) channels are essential for the rapid upstroke of action potentials and the propagation of electrical signals in nerves and muscles. Defects of Na_v channels are associated with a variety of channelopathies. More than 1000 disease-related mutations have been identified in Na_v channels, with Na_v1.1 and Na_v1.5 each harboring more than 400 mutations. Na_v channels represent major targets for a wide array of neurotoxins and drugs. Atomic structures of Na_v channels are required to understand their function and disease mechanisms. The recently determined atomic structure of the rabbit voltage-gated calcium (Ca_v) channel Ca_v1.1 provides a template for homology-based structural modeling of the evolutionarily related Na_v channels. In this Resource article, we summarized all the reported disease-related mutations in human Nav channels, generated a homologous model of human Na_v1.7, and structurally mapped disease-associated mutations. Before the determination of structures of human Na_v channels, the analysis presented here serves as the base framework for mechanistic investigation of Na_v channelopathies and for potential structure-based drug discovery.

Key words： Na_v channels; channelopathy; Na_v1.7; structure modeling; pain

References

1 ArnoldWD, FeldmanDH, RamirezS, HeL, KassarD, QuickA, KlassenTL, LaraM, NguyenJ, KisselJT (2015) Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.Ann Neurol77:840–850

2 BlanchardMG, WillemsenMH, WalkerJB, Dib-HajjSD, WaxmanSG, JongmansMC, KleefstraT, van de WarrenburgBP, PraamstraP, NicolaiJ (2015) De novo gain-of-function and loss-offunction mutations of SCN8A in patients with intellectual disabilities and epilepsy.J Med Genet52:330–337

3 CatterallWA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.Neuron26:13–25

4 CatterallWA (2012a) Sodium channel mutations and epilepsy.In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper’s basic mechanisms of the epilepsies. National Center for Biotechnology Information (US), Bethesda

5 CatterallWA (2012b) Voltage-gated sodium channels at 60: structure, function and pathophysiology.J Physiol590:2577–2589

6 CatterallWA (2014) Structure and function of voltage-gated sodium channels at atomic resolution.Exp Physiol99:35–51

7 CatterallWA, GoldinAL, WaxmanSG (2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.Pharmacol Rev57:397–409

8 CatterallWA, KalumeF, OakleyJC (2010) NaV1.1 channels and epilepsy.J Physiol588:1849–1859

9 ChoiJS, Dib-HajjSD, WaxmanSG (2006) Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy.Neurology67:1563–1567

10 ChoiJS, ZhangL, Dib-HajjSD, HanC, TyrrellL, LinZ, WangX, YangY, WaxmanSG (2009) Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.Exp Neurol216:383–389

11 ChoiJS, BoraleviF, BrissaudO, Sanchez-MartinJ, Te MorscheRH, Dib-HajjSD, DrenthJP, WaxmanSG (2011) Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons.Nat Rev Neurol7:51–55

12 CorrochanoS, MannikkoR, JoycePI, McGoldrickP, WettsteinJ, LassiG, Raja RayanDL, BlancoG, QuinnC, LiavasA (2014) Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.Brain137:3171–3185

13 CorryB, ThomasM (2012) Mechanism of ion permeation and selectivity in a voltage gated sodium channel.J Am Chem Soc134:1840–1846

14 de KovelCG, MeislerMH, BrilstraEH, van BerkestijnFM, van’t SlotR, van LieshoutS, NijmanIJ, O’BrienJE, HammerMF, EstacionM (2014) Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy.Epilepsy Res108:1511–1518

15 Dib-HajjSD, EstacionM, JareckiBW, TyrrellL, FischerTZ, LawdenM, CumminsTR, WaxmanSG (2008) Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable.Mol Pain4:37

16 Dib-HajjSD, YangY, BlackJA, WaxmanSG (2013) The Na(V)1.7 sodium channel: from molecule to man.Nat Rev Neurosci14:49–62

17 DjouhriL, NewtonR, LevinsonSR, BerryCM, CarruthersB, LawsonSN (2003) Sensory and electrophysiological properties of guineapig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein.J Physiol546:565–576

18 EscaygA, GoldinAL (2010) Sodium channel SCN1A and epilepsy: mutations and mechanisms.Epilepsia51:1650–1658

19 EstacionM, Dib-HajjSD, BenkePJ, Te MorscheRH, EastmanEM, MacalaLJ, DrenthJP, WaxmanSG (2008) NaV1.7 gain-offunction mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders.J Neurosci28:11079–11088

20 EstacionM, GasserA, Dib-HajjSD, WaxmanSG (2010) A sodium channel mutation linked to epilepsy increases ramp and persistent current of Nav1.3 and induces hyperexcitability in hippocampal neurons.Exp Neurol224:362–368

21 EstacionM, O’BrienJE, ConraveyA, HammerMF, WaxmanSG, Dib-HajjSD, MeislerMH(2014) A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy.Neurobiol Dis69:117–123

22 FaberCG, HoeijmakersJG, AhnHS, ChengX, HanC, ChoiJS, EstacionM, LauriaG, VanhoutteEK, GerritsMM (2012a) Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy.Ann Neurol71:26–39

23 FaberCG, LauriaG, MerkiesIS, ChengX, HanC, AhnHS, PerssonAK, HoeijmakersJG, GerritsMM, PierroT (2012b) Gain-offunction Nav1.8 mutations in painful neuropathy.Proc Natl Acad Sci USA109:19444–19449

24 FertlemanCR, BakerMD, ParkerKA, MoffattS, ElmslieFV, AbrahamsenB, OstmanJ,KlugbauerN, WoodJN, GardinerRM (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.Neuron52:767–774

25 GeorgeAL Jr (2005) Inherited disorders of voltage-gated sodium channels.J Clin Invest115:1990–1999

26 GoldinAL (2001) Resurgence of sodium channel research.Annu Rev Physiol63:871–894

27 GroomeJR, Lehmann-HornF, FanC, WolfM, WinstonV, MerliniL, Jurkat-RottK (2014) NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery.Brain137:998–1008

28 HanC, VasylyevD, MacalaLJ, GerritsMM, HoeijmakersJG, BekelaarKJ, Dib-HajjSD, FaberCG, MerkiesIS, WaxmanSG (2014) The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.J Neurol Neurosurg Psychiatry85:499–505

29 HanC, YangY, deGreef BT, HoeijmakersJG, GerritsMM, VerhammeC, QuJ, LauriaG, MerkiesIS, FaberCG (2015) The domain II S4-S5 linker in Nav1.9: a missense mutation enhances activation, impairs fast inactivation, and produces human painful neuropathy.Neuromol Med17:158–169

30 HeinemannSH, TerlauH, StuhmerW, ImotoK, NumaS (1992) Calcium channel characteristics conferred on the sodium channel by single mutations.Nature356:441–443

31 HuangJ, YangY, ZhaoP, GerritsMM, HoeijmakersJG, BekelaarK, MerkiesIS, FaberCG, Dib-HajjSD, WaxmanSG (2013) Smallfiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.J Neurosci33:14087–14097

32 HuangJ, HanC, EstacionM, VasylyevD, HoeijmakersJG, GerritsMM, TyrrellL, LauriaG, FaberCG, Dib-HajjSD (2014) Gainof-function mutations in sodium channel Na(v)1.9 in painful neuropathy.Brain137:1627–1642

33 JareckiBW, SheetsPL, JacksonJO 2nd, CumminsTR (2008) Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation.J Physiol586:4137–4153

34 KimJB (2014) Channelopathies.Korean J Pediatr57:1–18

35 KistAM, SagafosD, RushAM, NeacsuC, EberhardtE, SchmidtR, LundenLK, OrstavikK, KaluzaL, MeentsJ (2016) SCN10A mutation in a patient with erythromelalgia enhances C-fiber activity dependent slowing.PLoS One11:e0161789

36 LampertA, Dib-HajjSD, TyrrellL, WaxmanSG (2006) Size matters: erythromelalgia mutation S241T in Nav1.7 alters channel gating.J Biol Chem281:36029–36035

37 LampertA, O’ReillyAO, ReehP, LefflerA (2010) Sodium channelopathies and pain.Pflugers Arch460:249–263

38 LaurentG, SaalS, AmarouchMY, BeziauDM, MarsmanRF, FaivreL, BarcJ, DinaC, BertauxG, BarthezO (2012) Multifocal ectopic Purkinje-related premature contractions: a new SCN5Arelated cardiac channelopathy.J Am Coll Cardiol60:144–156

39 LauxmannS,Boutry-KryzaN,RivierC,MuellerS,HedrichUB,MaljevicS, SzepetowskiP, LercheH, LescaG(2013) An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na(+) current.Epilepsia54:e117–e121

40 LeipoldE, LiebmannL, KorenkeGC, HeinrichT, GiesselmannS, BaetsJ, EbbinghausM, GoralRO, StodbergT, HenningsJC (2013) A de novo gain-of-function mutation in SCN11A causes loss of pain perception.Nat Genet45:1399–1404

41 LeipoldE, Hanson-KahnA, FrickM, GongP, BernsteinJA, VoigtM, KatonaI, OliverGoralR, AltmullerJ, NurnbergP (2015) Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant.Nat Commun6:10049

42 LiaoY, DeprezL, MaljevicS, PitschJ, ClaesL, HristovaD, JordanovaA, Ala-MelloS, Bellan-KochA, BlazevicD (2010) Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy.Brain133:1403–1414

43 LossinC, WangDW, RhodesTH, VanoyeCG, GeorgeAL Jr (2002) Molecular basis of an inherited epilepsy.Neuron34:877–884

44 MakiyamaT, AkaoM, ShizutaS, DoiT, NishiyamaK, OkaY, OhnoS, NishioY, TsujiK, ItohH (2008) A novel SCN5A gain-offunction mutation M1875T associated with familial atrial fibrillation.J Am Coll Cardiol52:1326–1334

45 MantegazzaM, GambardellaA, RusconiR, SchiavonE, AnnesiF, CassuliniRR, LabateA, CarrideoS, ChifariR, CaneviniMP (2005) Identification of an Nav1.1 sodium channel (SCN1A) lossof-function mutation associated with familial simple febrile seizures.Proc Natl Acad Sci USA102:18177–18182

46 MisraSN, KahligKM, GeorgeAL Jr (2008) Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatalinfantile seizures.Epilepsia49:1535–1545

47 MOE (2016) Molecular operating environment (MOE), 2013.08.Chemical Computing Group Inc, Montreal

48 OlsonTM, MichelsVV, BallewJD, ReynaSP, KarstML, HerronKJ, HortonSC, RodehefferRJ, AndersonJL (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.JAMA293:447–454

49 PayandehJ, ScheuerT, ZhengN, CatterallWA (2011) The crystal structure of a voltage-gated sodium channel.Nature475:353–358

50 PlummerNW, MeislerMH (1999) Evolution and diversity of mammalian sodium channel genes.Genomics57:323–331

51 RemmeCA, VerkerkAO, NuyensD, van GinnekenAC, van BrunschotS, BeltermanCN, WildersR, van RoonMA, TanHL, WildeAA (2006) Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.Circulation114:2584–2594

52 ShiX, YasumotoS, KurahashiH, NakagawaE, FukasawaT, UchiyaS, HiroseS (2012) Clinical spectrum of SCN2A mutations.Brain Dev34:541–545

53 SmitsJP, KoopmannTT, WildersR, VeldkampMW, OpthofT, BhuiyanZA, MannensMM, BalserJR, TanHL, BezzinaCR (2005) A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families.J Mol Cell Cardiol38:969–981

54 SongW, ShouW (2012) Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.Pediatr Cardiol33:943–949

55 SunYM, FavreI, SchildL, MoczydlowskiE (1997) On the structural basis for size-selective permeation of organic cations through the voltage-gated sodium channel—effect of alanine mutations at the DEKA locus on selectivity, inhibition by Ca2+ and H+, and molecular sieving.J Gen Physiol110:693–715

56 SuterMR, BhuiyanZA, LaedermannCJ, KuntzerT, SchallerM, StauffacherMW, RouletE, AbrielH, DecosterdI, WiderC (2015) p. L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder.Anesthesiology122:414–423

57 SwanH, AmarouchMY, LeinonenJ, MarjamaaA, KuceraJP, Laitinen-ForsblomPJ, LahtinenAM, PalotieA, KontulaK, ToivonenL (2014) Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.Circ Cardiovasc Genet7:771–781

58 TanHL, Bink-BoelkensMT, BezzinaCR, ViswanathanPC, Beaufort-KrolGC, van TintelenPJ, vanden Berg MP, WildeAA, BalserJR (2001) A sodium-channel mutation causes isolated cardiac conduction disease.Nature409:1043–1047

59 TikhonovDB, ZhorovBS (2012) Architecture and pore block of eukaryotic voltage-gated sodium channels in view of NavAb bacterial sodium channel structure.Mol Pharmacol82:97–104

60 VanoyeCG, GurnettCA, HollandKD, GeorgeAL Jr, KearneyJA (2014) Novel SCN3A variants associated with focal epilepsy in children.Neurobiol Dis62:313–322

61 VassilevPM, ScheuerT, CatterallWA (1988) Identification of an intracellular peptide segment involved in sodium channel inactivation.Science241:1658–1661

62 VeeramahKR, O’BrienJE, MeislerMH, ChengX, Dib-HajjSD, WaxmanSG, TalwarD, GirirajanS, EichlerEE, RestifoLL (2012) De novo pathogenic SCN8A mutation identified by wholegenome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP.Am J Hum Genet90:502–510

63 VeermanCC, WildeAA, LodderEM (2015) The cardiac sodium channel gene SCN5A and its gene product NaV1.5: role in physiology and pathophysiology.Gene573:177–187

64 WagnonJL, BarkerBS, HounshellJA, HaaxmaCA, ShealyA, MossT, ParikhS, MesserRD, PatelMK, MeislerMH (2016) Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy.Ann Clin Transl Neurol3:114–123

65 WestJW, PattonDE, ScheuerT, WangY, GoldinAL, CatterallWA (1992) A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation.Proc Natl Acad Sci USA89:10910–10914

66 WuJ, YanZ, LiZ, YanC, LuS, DongM, YanN (2015) Structure of the voltage-gated calcium channel Cav1.1 complex.Science350:aad2395

67 WuJ, YanZ, LiZ, QianX, LuS, DongM, ZhouQ, YanN (2016) Structure of the voltage-gated calcium channel Cav1.1 at 3.6 A resolution.Nature537:191–196

68 YangY, Dib-HajjSD, ZhangJ, ZhangY, TyrrellL, EstacionM, WaxmanSG (2012) Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)1.7 mutant channel.Nat Commun3:1186

69 YangY, HuangJ, MisMA, EstacionM, MacalaL, ShahP, SchulmanBR, HortonDB, Dib-HajjSD, WaxmanSG (2016) Nav 1.7-A1632G mutation from a family with inherited erythromelalgia: enhanced firing of dorsal root ganglia neurons evoked by thermal stimuli.J Neurosci36:7511–7522

70 ZaharievaIT, ThorMG, OatesEC, vanKarnebeek C, HendsonG, BlomE, WittingN, RasmussenM, GabbettMT, RavenscroftG (2016) Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’ congenital myopathy.Brain139:674–691

71 ZhangX, RenW, DeCaenP, YanC, TaoX, TangL, WangJ, HasegawaK, KumasakaT, HeJ (2012) Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel.Nature486:130–134

72 ZhangXY, WenJ, YangW, WangC, GaoL, ZhengLH, WangT, RanK, LiY, LiX (2013) Gain-of-function mutations in SCN11A cause familial episodic pain.Am J Hum Genet93:957–966